New therapy approved for locally advanced or metastatic bladder cancer, and court ruling could lead to cost hikes for certain cancer screenings.

by Thomas Celona

Immunotherapies poised to change care in advanced endometrial cancer, and the end of pandemic protection expected to result in loss of health coverage for 15 million people.

by Eric Fitzsimmons

Drug shortage affects patients with advanced prostate cancer, and military pilots and ground crews have increased cancer rates.

by Marci A. Landsmann

Active monitoring a viable choice for some with prostate cancer, and cancer’s effects on women’s sexual activity not addressed by providers.

by Kevin McLaughlin

The FDA sets rule that requires mammography providers to notify women who have dense breasts, and the ‘Jimmy Carter effect’ on immunotherapy treatment.

by Eric Fitzsimmons

Exercising only 11 minutes per day can reduce your cancer risk, and new robotic technology helps detect early-stage lung cancer.

by Thomas Celona

Aggressive end-of-life measures are common in people with advanced cancer in nursing homes, and findings suggest immune checkpoint inhibitors could one day be the preferred treatment in localized cancer.

by Marci A. Landsmann

More older women with breast cancer may not need radiation therapy, and supply shortages hinder bladder cancer treatment.

by Kevin McLaughlin

Patients who receive certain forms of chemo face long-term risk for heart failure, and screening levels for certain cancers remain below expectations.

by Thomas Celona

Group says more women should consider removing fallopian tubes to lower ovarian cancer risk, and treatment guidelines can lead to arbitrary age cutoffs.

by Eric Fitzsimmons